发明名称 HCV PROTEASE INHIBITORS
摘要 The present invention discloses a compound of general formula (I); A is O, S, CH, NH or NR', when O links with Z 3 , Z 1 is N or CR Z1 , Z 2 is CR Z2 , when Z 1 links with O, Z 2 is CH, Z 3 is C-Ar; Ra, Rb, Rc and Rd independently is H, OH, halogen or -Y 1 -R m ; A 1 is NH or CH 2 ; R 1 ' is alkyl, aryl, cycloalkyl, heterocycloalkyl or heteroaryl; A 2 is N, O or linking bond; R 1 is hydrogen, or, R 1 linking covalently with R 3 forms C 5 -C 9 saturated or unsaturated hydrocarbon chain substituted by O or N; R 3 is alkyl, cycloalkyl, heterocycloalkyl, alkyl substituted by cycloalky etc; R 4 is alkoxy-CO, alkyl-NHCO, (alkyl) 2 NCO, or formyl substituted by aryl, cycloalkyl, heterocycloalkyl.
申请公布号 EP2740734(A1) 申请公布日期 2014.06.11
申请号 EP20120820086 申请日期 2012.07.23
申请人 SHANGHAI TANGRUN PHARMACEUTICALS, CO. LTD 发明人 ZHANG, Suoming
分类号 C07D491/048;A61K31/4355;A61K31/4365;A61K31/437;A61P31/14;C07D207/16;C07D495/04;C07K5/078;C07K5/08;C07K5/083 主分类号 C07D491/048
代理机构 代理人
主权项
地址